Cresilon’s TRAUMAGEL receives Vizient Innovative Technology contract. Discover what this means for trauma care adoption and bleeding control devices.
Pillar Biosciences launches rapid AML sequencing panel as Creatv Bio liquid biopsy enters colorectal cancer trial. Explore what these tools mean for oncology research.
Creatv Bio’s LifeTracDx joins CytoDyn’s Phase 2 colorectal cancer trial as a liquid biopsy biomarker tool. Discover what this means for oncology diagnostics.
Adela’s methylome blood test may help detect immunotherapy response earlier in cancer care. Discover what the latest study reveals for clinicians and diagnostics markets.
France approves reimbursement for MR-guided focused ultrasound in essential tremor. Discover what the policy change means for neurosurgery and patient access.
FDA grants De Novo clearance to LifeVac as the first authorized anti choking device. Discover what this means for emergency airway care and medical device regulation.
HR HealthCare launches the EZ-Protect hydrophilic catheter line to reduce infection risk and improve portability. Discover what it means for urology care.
Neuspera Medical’s 12-month pivotal SNM trial shows 94% responder rates and zero infections. Analysing what this means for the SNM market. Read more.
Mitria Medical’s Subvalvular Spacer reaches the U.S. under FDA compassionate use. What it means for FMR patients and what clinical evidence still needs to come.
Soterix Medical wins FDA clearance for SPRY TMS in treatment-resistant major depression. What the clearance means for the neuromodulation market. Read the analysis.